Medicaid and Immunization Programs Collaboration Toolkit
This toolkit is designed to equip state Medicaid and immunization programs (IPs) with resources to help facilitate and support their goals.
Flu Resources
Explore AIM's hub of resources for communications and education around the flu vaccine. Materials developed by AIM and our partners are included in this collection.
National Influenza Vaccination Week 2022 Social Media Toolkit
Join AIM in building awareness for National Influenza Vaccination Week with these sample social media posts.
Public Health Thank You Day 2022 Awareness Campaign
AIM has resources for participating in Public Health Thank You Day 2022. Explore our social media, video (coming soon), and thank you badge.
Episode 5: AIMing to Inform Guest Stephanie Schauer
In this episode of AIMing to Inform with Stephanie Schauer, Ph.D., get tips on team management, avoiding burnout, and so much more.
Voices for Vaccines Community Resources
Voices for Vaccines is a family-led pro-vaccine organization providing credible, fact-based resources for families and communities. Find easy-to-understand resources for building vaccine confidence, learning about vaccine safety, and understanding community immunity.
Episode 4: AIMing to Inform Guest Dave McCormick
Learn how Dave McCormick has worked to reframe vaccine catch-up with new messages and vaccine touchpoints in this episode of AIMing to Inform.
Aluminum Adjuvants Talking Points
Vaccines include ingredients to help them do their work. Each ingredient used to make a vaccine has a specific purpose. Certain ingredients, just like preservatives in foods, help keep vaccines safe from contamination and toxins that could make us sick.
Annual Influenza Update & Communications Training
AIM hosted the Annual Influenza Update and Communications Training webinar on September 20, 2022, and discussed what to expect this upcoming influenza season.
Updated COVID-19 Vaccine Booster Doses
Learn more about the two new Omicron (bivalent) vaccines, Pfizer and Moderna, which were recently authorized to be used as booster doses to help protect against the Omicron variants of the virus that causes COVID-19.